Search

The Drug Discovery Working Group of AseBio has developed the document "New Technologies in the Drug Discovery Process," addressing trends and barriers in the biotech sector regarding the use of

We talked to with Richard Borreani, Public Affairs, Science & Sustainability Iberia at Bayer, the Gold Sponsor of BIOSPAIN 2023, about new genomic techniques and the challenge of their regulation in

On 20 and 21 September, CEISA will be present at Farmaforum, one of the most important events in the pharmaceutical sector in Spain.

We analyze the potential of artificial intelligence as one of the technologies poised to revolutionize healthcare, with Owkin, Bronze Sponsor of BIOSPAIN 2023.

Oriol Penon, Director of Strategy and Innovation at Asphalion, Silver Sponsor of BIOSPAIN 2023, analyzes the main regulatory barriers in accessing innovative medications.

We spoke with Chus Castillo, Partner Consulting Iberia at Alira Health, Gold Sponsor of BIOSPAIN 2023, about the impact of the new HTA regulation on access to innovative medicines in Europe.

We analyze the role of epigenetics in cancer research with Douglas Faller, Chief Medical Officer of Oryzon, Gold Sponsor of BIOSPAIN 2023.

We analyze Spain's entrepreneurial capacity under the brand Spain Up Nation, an initiative of the Government of Spain and Platinum Sponsor of BIOSPAIN 2023, with José Bayón, CEO.

We discuss the launch of BME Scale, a new market primarily aimed at "scale-ups," with Jesús González, Managing Director of BME Growth, a Bronze Sponsor of BIOSPAIN 2023.

The new edition of the international flagship event in the biotech sector will take place in Barcelona from September 26 to 28, in collaboration with Biocat, the Government of Catalonia, and the

We spoke with Cristina Cortés, manager at Ayming, Bronze Sponsor of BIOSPAIN 2023, about the role of private financing in the biotechnology sector.

We spoke with Raúl Martín-Ruiz, partner at Ysios Capital, Gold Sponsor of BIOSPAIN 2023, about how to transform scientific knowledge into a successful company and the major challenges that

We spoke with Cati Ana Rosselló, Head of CMC at Laminar Pharma, a Bronze Sponsor of BIOSPAIN 2023, about the results of the LAM561 trials against glioblastoma.

The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based catheter for the treatment of pulmonary hypertension, with initial focus on the

We spoke with Clara Campàs, director and co-founder of Asabys, Gold Sponsor of BIOSPAIN 2023, to learn all the details about the launch of the Sabadell Asabys Health Innovation Investments II (SAHII 2

The Galician company continues its national projection responding to the specific needs of its customers.

The European project ShapingBio, created with the aim of better understanding and enhancing knowledge of the innovation ecosystem in the European bioeconomy sector, will be present at BIOSPAIN.

The company specialises in the development of molecules for oncological and gastrointestinal immunological treatments and has a drug in clinical phase IIa for ulcerative colitis and one in clinical